52 related articles for article (PubMed ID: 22842007)
1. Contribution of β-adrenergic receptors to exercise-induced bronchodilatation in healthy humans.
Antonelli A; Torchio R; Bertolaccini L; Terzi A; Rolfo F; Agostoni P; Gulotta C; Brusasco V; Pellegrino R
Respir Physiol Neurobiol; 2012 Oct; 184(1):55-9. PubMed ID: 22842007
[TBL] [Abstract][Full Text] [Related]
2. Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant?
Agostoni P; Contini M; Cattadori G; Apostolo A; Sciomer S; Bussotti M; Palermo P; Fiorentini C
Eur J Heart Fail; 2007 Aug; 9(8):827-33. PubMed ID: 17561440
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective effects of (R)- and (S)-carvedilol in humans.
Stoschitzky K; Koshucharova G; Lercher P; Maier R; Sakotnik A; Klein W; Liebmann PM; Lindner W
Chirality; 2001 Jul; 13(7):342-6. PubMed ID: 11400186
[TBL] [Abstract][Full Text] [Related]
4. Changes in platelet size and spleen volume in response to selective and non-selective beta-adrenoceptor blockade in hypertensive patients.
Bakovic D; Pivac N; Eterovic D; Palada I; Valic Z; Paukovic-Sekulic B; Dujic Z
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):441-6. PubMed ID: 19702597
[TBL] [Abstract][Full Text] [Related]
5. [Acute effect of inhaled beta(2)-agonists with different type of intrinsic activity on airway resistance in healthy volunteers].
Kishimoto N; Ohnishi H; Fujita J; Kamei T; Tada S; Ueda N
Arerugi; 2004 Apr; 53(4):417-22. PubMed ID: 15187486
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol but not metoprolol reduces beta-adrenergic responsiveness after complete elimination from plasma in vivo.
Kindermann M; Maack C; Schaller S; Finkler N; Schmidt KI; Läer S; Wuttke H; Schäfers HJ; Böhm M
Circulation; 2004 Jun; 109(25):3182-90. PubMed ID: 15184276
[TBL] [Abstract][Full Text] [Related]
7. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
[TBL] [Abstract][Full Text] [Related]
8. Assessment of beta-adrenergic receptor blockade after isamoltane, a 5-HT1-receptor active compound, in healthy volunteers.
Bauer K; Dietersdorfer F; Kaik G
Clin Pharmacol Ther; 1993 Jun; 53(6):675-83. PubMed ID: 8099863
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic update: non-selective beta- and alpha-adrenergic blockade in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure.
Sirak TE; Jelic S; Le Jemtel TH
J Am Coll Cardiol; 2004 Aug; 44(3):497-502. PubMed ID: 15358010
[TBL] [Abstract][Full Text] [Related]
10. Decreased heart rate recovery after exercise in patients with congestive heart failure: effect of beta-blocker therapy.
Racine N; Blanchet M; Ducharme A; Marquis J; Boucher JM; Juneau M; White M
J Card Fail; 2003 Aug; 9(4):296-302. PubMed ID: 13680550
[TBL] [Abstract][Full Text] [Related]
11. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
Hryniewicz K; Androne AS; Hudaihed A; Katz SD
Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816
[TBL] [Abstract][Full Text] [Related]
12. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
[TBL] [Abstract][Full Text] [Related]
13. Ventilatory effects of selective beta 1-(prenalterol) or beta 2-(salbutamol) adrenoceptor agonism in man.
Sorbini CA; Grassi V; Tantucci C; Corea L; Bentivoglio M; Verdecchia P; Motolese M
Int J Clin Pharmacol Ther Toxicol; 1984 Oct; 22(10):570-5. PubMed ID: 6150902
[TBL] [Abstract][Full Text] [Related]
14. Effects of acute inhalation of the bronchodilator, albuterol, on power output.
Signorile JF; Kaplan TA; Applegate B; Perry AC
Med Sci Sports Exerc; 1992 Jun; 24(6):638-42. PubMed ID: 1318486
[TBL] [Abstract][Full Text] [Related]
15. The effects of 2 beta-receptor blocking agents on the microcirculation of healthy subjects and of hypertensive patients.
Albrecht M; Haustein KO
Int J Clin Pharmacol Ther; 1997 Dec; 35(12):580-6. PubMed ID: 9455718
[TBL] [Abstract][Full Text] [Related]
16. A histamine H₂ receptor blocker ameliorates development of heart failure in dogs independently of β-adrenergic receptor blockade.
Takahama H; Asanuma H; Sanada S; Fujita M; Sasaki H; Wakeno M; Kim J; Asakura M; Takashima S; Minamino T; Komamura K; Sugimachi M; Kitakaze M
Basic Res Cardiol; 2010 Nov; 105(6):787-94. PubMed ID: 20852875
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure.
Vittorio TJ; Zolty R; Kasper ME; Khandwalla RM; Hirsh DS; Tseng CH; Jorde UP; Ahuja K
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):51-7. PubMed ID: 18287590
[TBL] [Abstract][Full Text] [Related]
18. Cerebral oxygenation decreases during exercise in humans with beta-adrenergic blockade.
Seifert T; Rasmussen P; Secher NH; Nielsen HB
Acta Physiol (Oxf); 2009 Jul; 196(3):295-302. PubMed ID: 19053964
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans.
Moro C; Crampes F; Sengenes C; De Glisezinski I; Galitzky J; Thalamas C; Lafontan M; Berlan M
FASEB J; 2004 May; 18(7):908-10. PubMed ID: 15033935
[TBL] [Abstract][Full Text] [Related]
20. Resting and postexercise hemodynamic effects of carvedilol, a beta-adrenergic blocker and precapillary vasodilator in hypertensive patients.
Leonetti G; Sampieri L; Cuspidi C; Boselli L; Terzoli L; Rupoli L; Zanchetti A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S94-6. PubMed ID: 2454377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
